GlassScriptPhysician profile
Smita Ramanadham
NPI 1548464324
$8,499.15
in general payments reported to CMS, 2019-2025
10 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2020: $339 · 2021: $5,432 · 2022: $487 · 2023: $811 · 2024: $509 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $992 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $992.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $5,120.00 | 2021 | |
| Mentor Worldwide LLC | $996.26 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Allergan, INC. | $579.95 | 2019-2022 | |
| Abbvie INC. | $553.83 | 2023-2024 | |
| Sientra, INC. | $475.90 | 2019-2020 | |
| Revance Therapeutics, INC. | $221.60 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $194.43 | 2019-2021 | |
| Tepha INC | $173.86 | 2019 | |
| Motiva USA, LLC | $156.43 | 2025 | |
| Apyx Medical Corporation | $26.89 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smita Ramanadham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.